A new study which followed 2,000 women with breast cancer for twenty-years post-diagnosis has revealed that breast cancer is eleven different diseases, each with a different risk of coming back after treatment.
Rather than taking its cue from our northern neighbors, or the British National Health Services, it makes more sense for the healthcare reform movement to consider what is being done on the European continent.
The five-state deal between Blue Cross and Blue Shield of North Carolina and Cambia Health Solutions prevents Anthem from using the valuable Blues brand in new markets.
The benefits of probiotics are often unclear and misrepresented. A new paper clarifies the definition and role of probiotics. Rigorous scientific testing and precise use of the term probiotics will benefit consumers and microbes alike.
Are technology oligarchies good or bad for competition in the marketplace? Should the giant technology companies that own huge segments of their markets, be broken up to encourage more innovation and competition? Or is “big” good for consumers?
Not long ago, I received a treatment so unproven my insurance company wouldn’t pay for it. Third party payers have the power to persuade clinicians to provide promising but unproven treatments within the context of scientifically useful clinical trials…
The American Medical Association urged big social media and tech companies including Amazon, Facebook and Google to stop vaccine misinformation on their platforms.
A popular definition of consciousness is the awareness of internal and external environments. Since functional machines are aware of their environment, perhaps we should recognize that as consciousness.
Rite Aid’s CEO John Standley is leaving in a major management shakeup that follows a period of shareholder unrest and two failed merger attempts during his nine-year reign.